HCW Biologics (NASDAQ:HCWB) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of HCW Biologics (NASDAQ:HCWB – Free Report) to a hold rating in a research report sent to investors on Friday morning. Separately, Maxim Group cut their target price on HCW Biologics from $120.00 to $35.00 and set a “buy” rating on the stock in a research report on Thursday, May […]
Wall Street Zen upgraded shares of HCW Biologics (NASDAQ:HCWB – Free Report) to a hold rating in a research report sent to investors on Friday morning. Separately, Maxim Group cut their target price on HCW Biologics from $120.00 to $35.00 and set a “buy” rating on the stock in a research report on Thursday, May […]
